论文部分内容阅读
目的观察米非司酮应用于临床上子宫肌瘤患者治疗的效果。方法选取我院2011-11-2012-10子宫肌瘤患者110例,将所有的子宫肌瘤患者按照分段随机化分为对照组和观察组2组,各55例。对照组子宫肌瘤患者单独使用米非司酮的方案治疗,观察组再联合其他中药的方式治疗,观察2组患者的子宫、肌瘤的体积,患者的月经状况,测评2组的总有效率。结果观察组子宫肌瘤患者的肌瘤体积、子宫的体积、月经总量、月经时长的平均数值优于对照组,P<0.05。结论使用米非司酮对子宫肌瘤患者进行治疗的效果较好,能够缩小患者的子宫体积和肌瘤体积,并调整患者的月经量和月经时间,使其达到正常的范畴。
Objective To observe the effect of mifepristone on clinical treatment of uterine fibroids. Methods Select 110 cases of uterine fibroids from 2011-11 to 2012-10 in our hospital. All patients with uterine fibroids were divided into control group and observation group according to piecewise randomization. The patients in control group were treated with mifepristone alone and the observation group were treated with other traditional Chinese medicines. The volume of uterus and fibroids, the menstrual status of patients and the total effective rate . Results The average fibroid volume, uterine volume, total menstrual volume and menstrual duration in the observation group were better than those in the control group (P <0.05). Conclusion The use of mifepristone in patients with uterine fibroids treatment is better, can reduce the patient’s uterine volume and fibroid volume, and adjust the patient’s menstrual flow and menstrual time, to reach the normal range.